Tag: therapeutics

Kapruvia recommended by NICE for CKD pruritus

Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics have announced that England’s National Institute for Health and Care Excellence (NICE) has recommended Kapruvia...

AstraZeneca shares real-world data from REVOLUTIONIZE I study

AstraZeneca has announced that it will showcase five real-world evidence (RWE) studies from its cardiovascular, renal and metabolism (CVRM) portfolio, reinforcing its commitment, it...

Study of metabolism may yield new target for kidney treatments

Metabolic changes related to an enzyme “helper molecule”—called nicotinamide adenine dinucleotide (NAD)—may serve as the basis for a future treatment or preventive measure for...

Talaris Therapeutics announces restructuring and clinical trial discontinuations

Talaris Therapeutics has announced that it has completed a review of its business and programme prospects. Based on this review, Talaris has decided to...